secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcellx, Inc. (ACLX)
CIK:        0001786205
Form:       8-K
Filed at:   2025-03-20T23:59:59+00:00
Accession:  0001193125-25-058978
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcellx appoints Andrew Galligan and Kristin Myers to board; Derek Yoon resigns
-------------------------------------------------------------------------------

- Derek Yoon resigned from the board effective March 18, 2025; no disagreements.
- Board size expanded from 7 to 8; Galligan and Myers appointed as Class I and III directors.
- Galligan brings financial leadership (ex-CFO of Nevro, Ooma); Myers adds payer/provider expertise (COO of Blue Cross Blue Shield Assn.).
- New directors receive $50k annual retainer, $850k initial option grant (3-yr vest), and $425k annual option grant.
- Company highlights anito-cel progress and expects commercial launch in 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1786205/000119312525058978/0001193125-25-058978-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1786205/000119312525058978/d905953d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-058978

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer